Novel PARP-1 Inhibitor Scaffolds Disclosed by a Dynamic Structure-Based Pharmacophore Approach-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel PARP-1 Inhibitor Scaffolds Disclosed by a Dynamic Structure-Based Pharmacophore Approach

Published:2017-01-25 Issue:1 Volume:12 Page:e0170846
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Baptista Salete J.,Silva Maria M. C.,Moroni Elisabetta,Meli Massimiliano,Colombo Giorgio,Dinis Teresa C. P.,Salvador Jorge A. R.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Concepts and Molecular Aspects in the Polypharmacology of PARP-1 Inhibitors;D Passeri;ChemMedChem,2016

2. Poly(ADP-ribose) polymerase 1 (PARP1) in atherosclerosis: from molecular mechanisms to therapeutic implications;S Xu;Med Res Rev,2014

3. Deciphering the insights of poly(ADP-ribosylation) in tumor progression;MI Rodriguez;Med Res Rev,2015

4. Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases;J Morales;Critical reviews in eukaryotic gene expression,2014

5. Scott CL, Swisher EM, Kaufmann SH. Poly (ADP-ribose) polymerase inhibitors: recent advances and future development. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2015;33(12):1397–406. Epub 2015/03/18. PubMed Central PMCID: PMCPmc4517072.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the expression and purification of human PARP1: A user-friendly protocol;Protein Expression and Purification;2023-11

2. In-silico method for elucidation of prodigiosin as PARP-1 inhibitor a prime target of Triple-negative breast cancer;Bioorganic Chemistry;2023-09

3. An overview of compound properties, multiparameter optimization, and computational drug design methods for PARP-1 inhibitor drugs;European Journal of Medicinal Chemistry;2023-04

4. Recent advances in structural types and medicinal chemistry of PARP-1 inhibitors;Medicinal Chemistry Research;2022-06-10

5. Evaluation of anticancer activity of N H/N-Me Aziridine derivatives as a potential poly (ADP-ribose) polymerase 1 inhibitor;Journal of Molecular Structure;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3